Literature DB >> 18378712

Radiofungicidal effects of external gamma radiation and antibody-targeted beta and alpha radiation on Cryptococcus neoformans.

Ruth A Bryan1, Xianchun Huang, Alfred Morgenstern, Frank Bruchertseifer, Arturo Casadevall, Ekaterina Dadachova.   

Abstract

We evaluated the clonogenic survival, membrane permeability, metabolic activity (XTT reduction), and apoptosis (FLICA binding) of Cryptococcus neoformans cells subjected to gamma rays from an external source, and beta and alpha particles delivered to fungal cells by capsule-specific antibody. We found that gamma, beta, and alpha radiation affected cells through different pathways.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18378712      PMCID： PMC2415782          DOI： 10.1128/AAC.01245-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  How and why does radioimmunotherapy work?

Authors:  Roger M Macklis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-08-01       Impact factor: 7.038

2.  Production of Ac-225 from Th-229 for targeted alpha therapy.

Authors:  C Apostolidis; R Molinet; G Rasmussen; A Morgenstern
Journal:  Anal Chem       Date:  2005-10-01       Impact factor: 6.986

3.  Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.

Authors:  A Casadevall; J Mukherjee; S J Devi; R Schneerson; J B Robbins; M D Scharff
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

4.  Flow cytometry and cell sorting for yeast viability assessment and cell selection.

Authors:  D Deere; J Shen; G Vesey; P Bell; P Bissinger; D Veal
Journal:  Yeast       Date:  1998-01-30       Impact factor: 3.239

5.  Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents.

Authors:  S P Hawser; H Norris; C J Jessup; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 6.  Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction.

Authors:  Michael V Berridge; Patries M Herst; An S Tan
Journal:  Biotechnol Annu Rev       Date:  2005

7.  Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans.

Authors:  R A Bryan; O Zaragoza; T Zhang; G Ortiz; A Casadevall; E Dadachova
Journal:  Eukaryot Cell       Date:  2005-02

Review 8.  Apoptosis in yeast.

Authors:  Frank Madeo; Eva Herker; Silke Wissing; Helmut Jungwirth; Tobias Eisenberg; Kai-Uwe Fröhlich
Journal:  Curr Opin Microbiol       Date:  2004-12       Impact factor: 7.934

9.  Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection.

Authors:  Ekaterina Dadachova; Antonio Nakouzi; Ruth A Bryan; Arturo Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

10.  Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.

Authors:  Ekaterina Dadachova; Roger W Howell; Ruth A Bryan; Annie Frenkel; Joshua D Nosanchuk; Arturo Casadevall
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057
View more
  9 in total

1.  Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent mice.

Authors:  Zewei Jiang; Ruth A Bryan; Alfred Morgenstern; Frank Bruchertseifer; Arturo Casadevall; Ekaterina Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cells.

Authors:  Ruth A Bryan; Zewei Jiang; Xianchun Huang; Alfred Morgenstern; Frank Bruchertseifer; Rani Sellers; Arturo Casadevall; Ekaterina Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

3.  Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells.

Authors:  Ruth A Bryan; Zewei Jiang; Alfred Morgenstern; Frank Bruchertseifer; Arturo Casadevall; Ekaterina Dadachova
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

4.  Radioimmunotherapy of infection with Bi-labeled antibodies.

Authors:  Ekaterina Dadachova
Journal:  Curr Radiopharm       Date:  2008-09-01

5.  Radiolabeled antibodies for therapy of infectious diseases.

Authors:  Ekaterina Dadachova; Arturo Casadevall
Journal:  Microbiol Spectr       Date:  2014-11

Review 6.  Radioimmunotherapy of infectious diseases.

Authors:  Ekaterina Dadachova; Arturo Casadevall
Journal:  Semin Nucl Med       Date:  2009-03       Impact factor: 4.446

7.  Cryptococcus neoformans as a Model for Radioimmunotherapy of Infections.

Authors:  Ekaterina Dadachova; Arturo Casadevall
Journal:  Interdiscip Perspect Infect Dis       Date:  2011-05-24

8.  Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens.

Authors:  Joshua D Nosanchuk; Ekaterina Dadachova
Journal:  Front Microbiol       Date:  2012-01-12       Impact factor: 5.640

9.  Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells.

Authors:  Mareike Roscher; Inis Hormann; Oliver Leib; Sebastian Marx; Josue Moreno; Erich Miltner; Claudia Friesen
Journal:  Oncotarget       Date:  2013-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.